NO20054369L - Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse - Google Patents
Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelseInfo
- Publication number
- NO20054369L NO20054369L NO20054369A NO20054369A NO20054369L NO 20054369 L NO20054369 L NO 20054369L NO 20054369 A NO20054369 A NO 20054369A NO 20054369 A NO20054369 A NO 20054369A NO 20054369 L NO20054369 L NO 20054369L
- Authority
- NO
- Norway
- Prior art keywords
- constipation
- prophylaxis
- treatment
- ibat inhibitor
- ibat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
SAMMENDRAG Anvendelse av en IBAT-inhibitor ved behandling og/eller profylakse av forstoppelse hos et varmblodig dyr, for eksempel et menneske.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0307918.3A GB0307918D0 (en) | 2003-04-05 | 2003-04-05 | Therapeutic use |
PCT/GB2004/001396 WO2004089350A1 (en) | 2003-04-05 | 2004-04-01 | Use of an ibat inhibitor for the treatment of prophylaxis of constipation |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20054369D0 NO20054369D0 (no) | 2005-09-21 |
NO20054369L true NO20054369L (no) | 2005-11-15 |
NO335140B1 NO335140B1 (no) | 2014-09-29 |
Family
ID=9956272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054369A NO335140B1 (no) | 2003-04-05 | 2005-09-21 | Kjemiske forbindelser for behandling og profylakse av forstoppelse samt farmasøytiske preparater inneholdende samme |
Country Status (33)
Country | Link |
---|---|
US (1) | US7514421B2 (no) |
EP (2) | EP1610770B1 (no) |
JP (2) | JP4870552B2 (no) |
KR (1) | KR101321577B1 (no) |
CN (1) | CN100366241C (no) |
AR (1) | AR043985A1 (no) |
AT (2) | ATE513550T1 (no) |
AU (1) | AU2004228731B2 (no) |
BR (1) | BRPI0408858A (no) |
CA (1) | CA2520109C (no) |
CO (1) | CO5640076A2 (no) |
CY (2) | CY1107424T1 (no) |
DE (1) | DE602004012079T2 (no) |
DK (2) | DK1610770T3 (no) |
ES (2) | ES2299832T3 (no) |
GB (1) | GB0307918D0 (no) |
HK (1) | HK1085666A1 (no) |
IL (1) | IL170913A (no) |
IS (1) | IS8113A (no) |
MX (1) | MXPA05010706A (no) |
MY (1) | MY137757A (no) |
NO (1) | NO335140B1 (no) |
NZ (1) | NZ542835A (no) |
PL (2) | PL1894564T3 (no) |
PT (2) | PT1894564E (no) |
RU (2) | RU2342928C2 (no) |
SA (1) | SA04250066B1 (no) |
SI (2) | SI1610770T1 (no) |
TW (1) | TWI338577B (no) |
UA (1) | UA84141C2 (no) |
UY (1) | UY28258A1 (no) |
WO (1) | WO2004089350A1 (no) |
ZA (1) | ZA200507996B (no) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
IL160691A0 (en) | 2001-09-08 | 2004-08-31 | Astrazeneca Ab | Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment of hyperlipidaemia |
GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
GB0304194D0 (en) | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
GB0307918D0 (en) * | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
AR057828A1 (es) * | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica |
ES2445049T3 (es) | 2007-03-08 | 2014-02-27 | Albireo Ab | Derivados del ácido 3-fenilpropiónico y su uso en el tratamiento de la enfermedad inflamatoria intestinal |
EP2367554A4 (en) | 2008-11-26 | 2020-03-25 | Satiogen Pharmaceuticals, Inc. | BILIARY ACID RECYCLING INHIBITORS FOR THE TREATMENT OF OBESITY AND DIABETES |
ES2552657T3 (es) * | 2010-05-26 | 2015-12-01 | Satiogen Pharmaceuticals, Inc. | Inhibidores del reciclado de ácidos biliares y saciógenos para el tratamiento de diabetes, obesidad, y afecciones gastrointestinales inflamatorias |
SG190029A1 (en) | 2010-11-08 | 2013-06-28 | Albireo Ab | Ibat inhibitors for the treatment of liver diseases |
BR112014010223B8 (pt) | 2011-10-28 | 2021-02-23 | Lumena Pharmaceuticals Llc | uso de uma composição compreendendo inibidores de reciclagem de ácido de bílis e forma de dosagem pediátrica |
CN104023718B (zh) | 2011-10-28 | 2017-04-05 | 鲁美纳医药公司 | 用于治疗高胆血症和胆汁淤积性肝病的胆汁酸再循环抑制剂 |
RU2015139732A (ru) | 2013-03-15 | 2017-04-24 | ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи | Ингибиторы рециркуляции желчных кислот для лечения пищевода барретта и гастроэзофагеальной рефлюксной болезни |
KR20230152818A (ko) | 2013-03-15 | 2023-11-03 | 샤이어 휴먼 지네틱 테라피즈 인크. | 원발성 담관염 및 염증성 장 질환 치료용 담즙산 재순환 억제제 |
JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
KR101420315B1 (ko) * | 2014-03-19 | 2014-07-17 | 남봉길 | 약학적 액제 조성물 |
KR102296314B1 (ko) | 2014-06-25 | 2021-09-01 | 이에이 파마 가부시키가이샤 | 고형 제제 및 그의 안정화 방법 |
KR102560954B1 (ko) | 2014-06-25 | 2023-07-31 | 이에이 파마 가부시키가이샤 | 고형 제제 및 그의 착색 방지 또는 착색 감소 방법 |
EP3012252A1 (en) | 2014-10-24 | 2016-04-27 | Ferring BV | Crystal modifications of elobixibat |
RU2018105869A (ru) | 2015-08-17 | 2019-09-19 | Ферринг Б.В. | Жидкие составы, содержащие пикосульфат и цитрат магния |
US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
SI3643718T1 (sl) | 2017-06-20 | 2023-11-30 | Takeda Pharmaceutical Company Limited | Heterociklična spojina in njena uporaba kot pozitivni alosterični modulator holinergičnega muskarinskega receptorja M1 |
CN111032019B (zh) | 2017-08-09 | 2022-07-05 | 阿尔比里奥公司 | 考来烯胺颗粒、口服考来烯胺制剂及其用途 |
US10428109B1 (en) | 2018-03-09 | 2019-10-01 | Elobix Ab | Process for the preparation of 1,5-benzothiazepine compounds |
CN111836804A (zh) | 2018-03-09 | 2020-10-27 | 埃洛比克斯股份公司 | 用于制备依洛昔巴特的方法 |
US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
EP3802504B1 (en) | 2018-06-05 | 2023-01-18 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
CA3100691A1 (en) | 2018-06-20 | 2019-12-26 | Albireo Ab | Crystal modifications of odevixibat |
US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
AU2020221239A1 (en) | 2019-02-12 | 2021-09-16 | Mirum Pharmaceuticals, Inc. | Methods for treating cholestasis |
JP2023504647A (ja) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
JP2023504645A (ja) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
CN114761080A (zh) | 2019-12-04 | 2022-07-15 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
EP4069247A1 (en) | 2019-12-04 | 2022-10-12 | Albireo AB | Benzothiadiazepine compounds and their use as bile acid modulators |
US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
JP2023537285A (ja) | 2020-08-03 | 2023-08-31 | アルビレオ・アクチボラグ | ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
AU2021379076A1 (en) | 2020-11-12 | 2023-06-08 | Albireo Ab | Odevixibat for treating progressive familial intrahepatic cholestasis (pfic) |
AU2021390172A1 (en) | 2020-12-04 | 2023-06-22 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
WO2022166680A1 (zh) * | 2021-06-25 | 2022-08-11 | 苏州科睿思制药有限公司 | 奥德昔巴特的晶型及其制备方法和用途 |
US20230338392A1 (en) | 2022-04-22 | 2023-10-26 | Albireo Ab | Subcutaneous administration of an asbt inhibitor |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO170760C (no) | 1985-01-10 | 1992-12-02 | Tanabe Seiyaku Co | Analogifremgangsmaate for fremstilling av terapeutisk aktive nafthalenderivater |
JPS6310746A (ja) | 1986-07-01 | 1988-01-18 | Tanabe Seiyaku Co Ltd | ナフタレン誘導体 |
US4900757A (en) | 1988-12-08 | 1990-02-13 | Merrell Dow Pharmaceuticals Inc. | Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane |
DE3930696A1 (de) | 1989-09-14 | 1991-03-28 | Hoechst Ag | Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel |
FI106800B (fi) | 1990-12-06 | 2001-04-12 | Hoechst Ag | Menetelmä uusien terapeuttisesti käyttökelpoisten dimeeristen sappihappojohdannaisten valmistamiseksi |
KR100252428B1 (ko) | 1991-10-17 | 2000-04-15 | 시오노 요시히코 | 리그난유사체,이의제조방법및이를함유한항지혈증제 |
AU653658B2 (en) | 1991-12-20 | 1994-10-06 | Hoechst Aktiengesellschaft | Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
JPH05186357A (ja) * | 1991-12-31 | 1993-07-27 | Shigeo Ochi | 飲食物消化分解産物吸収抑制手段 |
GB9201180D0 (en) * | 1992-01-21 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
GB9203347D0 (en) * | 1992-02-17 | 1992-04-01 | Wellcome Found | Hypolipidaemic compounds |
EP0573848B1 (de) | 1992-06-12 | 1997-12-03 | Hoechst Aktiengesellschaft | Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel |
ZA941003B (en) | 1993-02-15 | 1995-08-14 | Wellcome Found | Hypolipidaemic compounds |
IL108634A0 (en) | 1993-02-15 | 1994-05-30 | Wellcome Found | Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them |
CN1046937C (zh) | 1993-04-16 | 1999-12-01 | 盐野义制药株式会社 | 木酚素系化合物的制备方法 |
TW289021B (no) | 1993-05-08 | 1996-10-21 | Hoechst Ag | |
EP0624593A3 (de) | 1993-05-08 | 1995-06-07 | Hoechst Ag | Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel. |
TW289020B (no) | 1993-05-08 | 1996-10-21 | Hoechst Sktiengesellschaft | |
ZA956647B (en) | 1994-08-10 | 1997-02-10 | Wellcome Found | Hypolipidaemic compounds. |
US5994391A (en) | 1994-09-13 | 1999-11-30 | G.D. Searle And Company | Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
JP3304093B2 (ja) | 1994-09-13 | 2002-07-22 | モンサント カンパニー | 回腸の胆汁酸輸送及びタウロコール酸塩吸収の阻害活性を有する新規ベンゾチエピン類 |
GB9423172D0 (en) | 1994-11-17 | 1995-01-04 | Wellcom Foundation The Limited | Hypolipidemic benzothiazepines |
CN1110494C (zh) | 1996-03-11 | 2003-06-04 | G·D·瑟尔公司 | 具有作为回肠胆汁酸转运和牛磺胆酸盐吸收抑制剂活性的新的苯并噻庚因 |
EP0929575A4 (en) | 1996-08-23 | 2004-09-08 | Human Genome Sciences Inc | NEW HUMAN GROWTH FACTORS. |
JPH1072371A (ja) | 1996-08-28 | 1998-03-17 | Sankyo Co Ltd | 回腸型胆汁酸トランスポーター阻害剤 |
GB9704208D0 (en) | 1997-02-28 | 1997-04-16 | Glaxo Group Ltd | Chemical compounds |
WO1998040375A2 (en) | 1997-03-11 | 1998-09-17 | G.D. Searle & Co. | COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS |
DK0864582T3 (da) | 1997-03-14 | 2003-09-29 | Aventis Pharma Gmbh | Hypolidemiske 1,4-benzothiazepin-1,1-dioxider |
ATE268758T1 (de) | 1997-04-04 | 2004-06-15 | Aventis Pharma Gmbh | Hypolipidämische propanolaminderivate |
DE19845402B4 (de) | 1998-10-02 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
AU7552198A (en) | 1997-06-11 | 1998-12-30 | Sankyo Company Limited | Benzylamine derivatives |
AUPO763197A0 (en) | 1997-06-30 | 1997-07-24 | Sigma Pharmaceuticals Pty Ltd | Health supplement |
BR9814300A (pt) | 1997-12-19 | 2002-02-05 | Searle & Co | Método de preparação de óxidos de tetraidrobenzotiepina enanciomericamente enriquecidos |
GB9800428D0 (en) | 1998-01-10 | 1998-03-04 | Glaxo Group Ltd | Chemical compounds |
DE19825804C2 (de) | 1998-06-10 | 2000-08-24 | Aventis Pharma Gmbh | 1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE19845406C2 (de) | 1998-10-02 | 2001-10-18 | Aventis Pharma Gmbh | Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
DE19845405C2 (de) | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
DE19845403B4 (de) | 1998-10-02 | 2005-02-10 | Aventis Pharma Deutschland Gmbh | Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
AU1684400A (en) | 1998-12-11 | 2000-07-03 | Sankyo Company Limited | Substituted benzylamines |
HUP0201972A3 (en) | 1998-12-23 | 2005-06-28 | G D Searle Llc Chicago | Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
BR9916564A (pt) | 1998-12-23 | 2002-01-29 | Searle Llc | Combinações para indicações cardiovasculares |
HUP0104593A3 (en) | 1998-12-23 | 2004-10-28 | G D Searle Llc Chicago | Combinations of benzothiepine ileal bile acid transport inhibitor and nicotinic acid derivatives for cardiovascular indications |
ES2189529T3 (es) | 1998-12-23 | 2003-07-01 | Searle Llc | Combinaciones de inhiidores para el transporte de acidos biliares en el ileon y agentes complejantes para indicaciones cardiovasculares. |
BR9916565A (pt) | 1998-12-23 | 2002-01-29 | Searle Llc | Combinações de inibidores do transporte ácido da bile ileal e derivados do ácido fìbrico para indicações cardiovasculares |
CA2362147A1 (en) | 1999-02-12 | 2000-08-17 | Steve A. Kolodziej | 1,2-benzothiazepines for the treatment of hyperlipidemic diseases |
DE19916108C1 (de) | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung |
SE9901387D0 (sv) | 1999-04-19 | 1999-04-19 | Astra Ab | New pharmaceutical foromaulations |
US6287609B1 (en) * | 1999-06-09 | 2001-09-11 | Wisconsin Alumni Research Foundation | Unfermented gel fraction from psyllium seed husks |
TR200002099A3 (tr) | 1999-07-22 | 2001-06-21 | Sankyo Company Limited | Siklobüten türevleri, bunlarin hazirlanmasi ve terapötik kullanimlari |
WO2001034570A1 (fr) | 1999-11-08 | 2001-05-17 | Sankyo Company, Limited | Derives heterocycliques azotes |
CA2400021A1 (en) | 2000-02-18 | 2001-08-23 | Merck & Co., Inc. | Aryloxyacetic acids for diabetes and lipid disorders |
SE0000772D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | Chemical compounds |
AU2001247331A1 (en) | 2000-03-10 | 2001-09-24 | Pharmacia Corporation | Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders |
AU2001240115A1 (en) | 2000-03-10 | 2001-09-24 | Pharmacia Corporation | Method for the preparation of tetrahydrobenzothiepines |
US20020183307A1 (en) | 2000-07-26 | 2002-12-05 | Tremont Samuel J. | Novel 1,4-benzothiazephine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake |
SE0003766D0 (sv) | 2000-10-18 | 2000-10-18 | Astrazeneca Ab | Novel formulation |
EG26979A (en) * | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
WO2002053548A1 (en) | 2000-12-27 | 2002-07-11 | Banyu Pharmaceutical Co.,Ltd. | Benzothiazepine derivatives |
US6506921B1 (en) * | 2001-06-29 | 2003-01-14 | Virginia Tech Intellectual Properties, Inc. | Amine compounds and curable compositions derived therefrom |
GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
IL160691A0 (en) * | 2001-09-08 | 2004-08-31 | Astrazeneca Ab | Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment of hyperlipidaemia |
GB0201850D0 (en) * | 2002-01-26 | 2002-03-13 | Astrazeneca Ab | Therapeutic treatment |
GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
GB0216321D0 (en) | 2002-07-13 | 2002-08-21 | Astrazeneca Ab | Therapeutic treatment |
GB0304194D0 (en) | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
GB0307918D0 (en) * | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
-
2003
- 2003-04-05 GB GBGB0307918.3A patent/GB0307918D0/en not_active Ceased
-
2004
- 2004-04-01 UA UAA200508758A patent/UA84141C2/ru unknown
- 2004-04-01 JP JP2006506065A patent/JP4870552B2/ja not_active Expired - Lifetime
- 2004-04-01 PT PT07023058T patent/PT1894564E/pt unknown
- 2004-04-01 SI SI200430662T patent/SI1610770T1/sl unknown
- 2004-04-01 PL PL07023058T patent/PL1894564T3/pl unknown
- 2004-04-01 KR KR1020057018959A patent/KR101321577B1/ko active IP Right Grant
- 2004-04-01 PT PT04725081T patent/PT1610770E/pt unknown
- 2004-04-01 AT AT07023058T patent/ATE513550T1/de active
- 2004-04-01 DK DK04725081T patent/DK1610770T3/da active
- 2004-04-01 PL PL04725081T patent/PL1610770T3/pl unknown
- 2004-04-01 DK DK07023058.6T patent/DK1894564T3/da active
- 2004-04-01 WO PCT/GB2004/001396 patent/WO2004089350A1/en active IP Right Grant
- 2004-04-01 MX MXPA05010706A patent/MXPA05010706A/es active IP Right Grant
- 2004-04-01 CN CNB200480009415XA patent/CN100366241C/zh not_active Expired - Lifetime
- 2004-04-01 DE DE602004012079T patent/DE602004012079T2/de not_active Expired - Lifetime
- 2004-04-01 CA CA2520109A patent/CA2520109C/en not_active Expired - Lifetime
- 2004-04-01 ES ES04725081T patent/ES2299832T3/es not_active Expired - Lifetime
- 2004-04-01 EP EP04725081A patent/EP1610770B1/en not_active Expired - Lifetime
- 2004-04-01 RU RU2005128792/15A patent/RU2342928C2/ru active
- 2004-04-01 NZ NZ542835A patent/NZ542835A/en unknown
- 2004-04-01 ES ES07023058T patent/ES2368350T3/es not_active Expired - Lifetime
- 2004-04-01 AT AT04725081T patent/ATE387194T1/de active
- 2004-04-01 AU AU2004228731A patent/AU2004228731B2/en not_active Ceased
- 2004-04-01 EP EP07023058A patent/EP1894564B1/en not_active Expired - Lifetime
- 2004-04-01 SI SI200431710T patent/SI1894564T1/sl unknown
- 2004-04-01 BR BRPI0408858-1A patent/BRPI0408858A/pt not_active Application Discontinuation
- 2004-04-01 US US10/551,999 patent/US7514421B2/en not_active Expired - Lifetime
- 2004-04-02 MY MYPI20041236A patent/MY137757A/en unknown
- 2004-04-05 SA SA04250066A patent/SA04250066B1/ar unknown
- 2004-04-05 TW TW093109383A patent/TWI338577B/zh active
- 2004-04-05 UY UY28258A patent/UY28258A1/es not_active Application Discontinuation
- 2004-04-06 AR ARP040101159A patent/AR043985A1/es not_active Application Discontinuation
-
2005
- 2005-09-15 IL IL170913A patent/IL170913A/en unknown
- 2005-09-21 NO NO20054369A patent/NO335140B1/no unknown
- 2005-10-03 ZA ZA200507996A patent/ZA200507996B/xx unknown
- 2005-10-25 CO CO05108676A patent/CO5640076A2/es not_active Application Discontinuation
- 2005-11-01 IS IS8113A patent/IS8113A/is unknown
-
2006
- 2006-05-16 HK HK06105682A patent/HK1085666A1/xx not_active IP Right Cessation
-
2008
- 2008-04-24 CY CY20081100461T patent/CY1107424T1/el unknown
- 2008-07-17 RU RU2008129204/15A patent/RU2482850C2/ru active
-
2011
- 2011-06-07 JP JP2011127175A patent/JP5421326B2/ja not_active Expired - Lifetime
- 2011-09-07 CY CY20111100862T patent/CY1111995T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054369L (no) | Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse | |
RS51903B (sr) | Formulacija aripiprazol kompleksa i postupak | |
DK1372650T3 (da) | Kombinationer indeholdende et antidiarrémiddel og en epothilon eller et epothilonderivat | |
ATE340171T1 (de) | Piperazinderivate zur behandlung bakterieller infektionen | |
ATE461217T1 (de) | Glp-1-verbindungen | |
DK1206474T3 (da) | Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer | |
BR0317130B1 (pt) | artigo de fumar, e, mÉtodo de melhoramento do odor residual de um artigo de fumar em um ambiente. | |
NO20071926L (no) | Anvendelse av en mTOR-inhibitor i behandling av uterint leioyom. | |
WO2004007743A3 (en) | Use of cpg nucleic acids in prion-disease | |
MX2007002277A (es) | Metodos para formar retinoides y usos de los mismos. | |
RS51138B (sr) | S-mirtazapin za lečenje nastupa vreline (valunga) | |
DK1738025T3 (da) | Fibrøse strukturer omfattende en overfladebehandlende sammensætning og en lotionsammensætning | |
AU2003249930A1 (en) | Proteaseome inhibitors for the treatment of herpesviridae infected individuals | |
DE50309647D1 (de) | Ng fibrotischer erkrankungen | |
IL139144A0 (en) | Mycobacterial inhibitors | |
WO2005077019A3 (en) | Protease inhibitors for treatment of wrinkles | |
IS7441A (is) | Peptíðdeformýlasatálmar | |
BR0017074A (pt) | Combinações de inibidor de ace-antagonista de vasopressina | |
DE60232650D1 (de) | Peptiddeformylaseinhibitoren | |
ATE364037T1 (de) | Tryptasehemmer | |
WO2003068224A3 (de) | Verwendung von inhibitoren des natrium-abhängigen chlorid-bicarbonat-austauschers zur behandlung von thrombotischen und inflammatorischer erkrankungen | |
UA10889U (uk) | Застосування 4-(n-бензил)амінокарбонілу-1-метилпіридинію йодиду як профілактичного інгібітора цитомегаловірусної інфекції людини | |
TW200500081A (en) | Novel rotaviruses and use thereof | |
TH90961B (th) | การรักษาเชิงบำบัด | |
UA40336A (uk) | Спосіб хірургічного лікування екстрапірамідних гіперкінезів у хворих із церебросудинною патологією |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: ALBIREO AB, SE |